main content start
Showing Results for: “Glycemic Index and Diabetes”
Sadaf Farooqi, MB, ChB (Hons), PhD, Named American Diabetes Association’s® 2019 Outstanding Scientific Achievement Award
The American Diabetes Association® (ADA) will present the 2019 Outstanding Scientific Achievement Award (OSAA) to Sadaf Farooqi, MB, ChB (Hons), PhD. Dr. Farooqi will be recognized with this honor, which is given annually for research in diabetes that demonstrates particular independence of thought and originality, during the ADA’s 79th Scientific Sessions, June 7-11, 2019, at the Moscone Convention Center in San Francisco. She will deliver her OSAA Lecture, titled “ Obesity and the Biology of Weight Regulation ,” during the National Scientific and Health Care Achievement Awards Presentation
American Diabetes Association Applauds Alabama Governor and State Legislature for Passing Bill to Cap Monthly Insulin Co-pays
The American Diabetes Association® (ADA) applauds Alabama Governor Kay Ivey today for signing House Bill 249, legislation that will cap insulin co-sharing at $100 per month for those on state-regulated health plans, without regard to the policy deductible, and regardless of the quantity or type of insulin needed to fill the insured patient's prescription. Bill sponsor, Representative Paul Lee, Chairman of the House Health Committee and Senator Tom Butler, Chairman of the Senate Veteran’s and Military Affairs Committee provided leadership on this important legislation to reduce the burden of
American Diabetes Association® Applauds Kentucky Governor and State Legislature for Passing Bill to Cap Monthly Insulin Co-pays
Today, the American Diabetes Association® (ADA) applauded Kentucky Governor Andy Beshear for signing legislation that will cap insulin co-pays at $30 per month, regardless of the quantity or type of insulin needed to fill the insured patient's prescription. Governor Beshear and bill sponsor Representative Danny Bentley provided expert leadership on this important legislation to reduce the burden of insulin costs for people living with diabetes. Kentucky joins 14 other states as well as the District of Columbia that have enacted insulin copay caps to reduce costs of this life-saving drug.
Study Finds Dramatic Drop in Ketoacidosis Rate after FreeStyle Libre System Initiation in People with Type 1 and Type 2 Diabetes
Reduced hospitalization rates among people with low self-monitoring of blood glucose (SMBG) are especially pronounced People using Abbott’s FreeStyle Libre, a sensor-based glucose monitoring system, experienced a considerable decrease in ketoacidosis-related hospitalizations—52% for type 1 diabetes and 47% for type 2 diabetes—according to the study titled “Dramatic Drop in Ketoacidosis Rate after FreeStyle Libre System Initiation in Type 1 and Type 2 Diabetes in France, Especially in People with Low Self-Monitoring of Blood Glucose (SMBG): A Nationwide Study,” presented today at the American
FDA Expands Remote Patient Monitoring in Hospitals for People with Diabetes During COVID-19; Manufacturers Donate CGM Supplies
American Diabetes Association ® partners with Abbott to donate 25,000 CGM sensors to hospitals across the country Recently, the Food and Drug Administration (FDA) issued guidance to expand the availability and capability of non-invasive remote monitoring devices during the COVID-19 pandemic. This change was made in an effort to improve the ability of health care providers to monitor their patients while reducing their exposure to the novel coronavirus. The new policy will apply to non-invasive patient monitoring technology, including continuous glucose monitors (CGM), and expands their
The American Diabetes Association Receives Health Equity Grant from the Pfizer Foundation to Help Improve the Health of Black Communities in the U.S.
Today, the American Diabetes Association ® (ADA) announced a two-year Accelerating Health Equity Grant awarded by the Pfizer Foundation to support a community garden and diabetes support program in Alabama and Florida. The ADA has partnered with local organizations in Montgomery, Alabama, and Tampa, Florida to develop innovative community-based intervention projects that will address social determinants of health and diabetes care. The ADA’s community impact project goals are to: Expand the 10-acre community garden created in Montgomery to increase access to healthy foods and diabetes support
$10 Million Commitment Made to The American Diabetes Association by CVS Health to Reach Five Million Patients and Transform Health Outcomes
Support increases access for people with diabetes and caregivers to education, resources, and guidance to improve their overall health through this partnership Today, the American Diabetes Association ® (ADA) and CVS Health (NYSE: CVS) established a new partnership to support families in helping to prevent and manage diabetes, as well as fund research on the devastating health disparities that fuel the diabetes epidemic. CVS Health has committed $10 million over three years to support people in their health journey of preventing and managing diabetes with increased awareness, knowledge, and
Give Today and Change lives!
With your support, the American Diabetes Association® can continue our lifesaving work to make breakthroughs in research and provide people with the resources they need to fight diabetes.